Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare disease where the body’s natural defenses, like antibodies, attack the covering of the nerves, called myelin, and damage nerve function. While symptoms aren’t the same for everyone, CIDP can make your arms and legs feel weak and slow your movements. The purpose of the ARISE Study is …
The Foundation for Peripheral Neuropathy and the Department of Defense Peer-Reviewed Medical Research Program Co-Host March 8 Webinar About Award Pre-Applications CHICAGO, Feb. 28, 2023 /PRNewswire/ — For the third consecutive year, peripheral neuropathy (PN) has been renewed for research funding by the Department of Defense Peer Reviewed Medical Research Program (PDMRP)’s $370 million fund. In advance of pre-application deadlines, the Foundation for Peripheral Neuropathy (FPN) and the …
Vitamin B6 toxicity is known to be a cause of peripheral neuropathy. There is debate regarding the threshold at which intake levels can cause neurological symptoms through vitamin B6. In a 2021 study from the Peripheral Neuropathy Research Registry (PNRR), funded by the Foundation for Peripheral Neuropathy, researchers asked if elevated plasma vitamin B6 levels …
Following over a year’s delay due to the COVID-19 pandemic, the IMAGiNe Study is finally back on track! The IMAGiNe Study (Immunoglobulin M(IgM)-Anti-myelin-associated-glycoprotein (MAG) Peripheral Neuropathy Study) is a research program that aims to create a standardized database and biobank to be used for the research and analysis of Anti-MAG peripheral neuropathy. The goal is to be able to …
The Foundation for Peripheral Neuropathy (FPN) is pleased to welcome the University of Michigan as a new site for patient enrollments into the Peripheral Neuropathy Research Registry. In this article, FPN’s Executive Director interviews the newest researcher to join this special team, Dr. Amro Stino, and why this new partnership will be fruitful for the …
FPN Welcomes the University of Michigan and Dr. Amro Stino Read More »
Do you have numbness and tingling or pain in your feet from diabetes? Do you have pain after shingles (postherpetic pain)? The Translational Pain Research Group at the Brigham and Women’s Hospital in Boston, Massachusetts, is seeking volunteers who have diabetic nerve pain or pain following shingles to participate in a research study. Volunteers who …
Erchonia Corporation is currently recruiting for a study on the effect of Low Level Laser Therapy on Diabetic Peripheral Neuropathy pain. This study can be found at ClinicalTrials.gov here. PURPOSE OF THE STUDY In this study, the Sponsor, Erchonia Corporation, and investigators are studying the use of a device called the Erchonia® FX-635™ that gives …
In January 2019, a study was published by the Journal of the Peripheral Nervous System on the design and characteristics of patient data collected from the Peripheral Neuropathy Research Registry (PNRR). This is the first ever overall study performed on this Patient Registry and one that truly highlights the importance of this dataset for current …
Key Data from FPN Patient Registry Highlighted in Top Medical Journal Read More »
In a new study from Washington University School of Medicine in St. Louis, scientists have blocked the destruction of nerve axons in mice, a step toward helping patients with various neurodegenerative disorders, including peripheral neuropathy. The findings of this report, originally reported by Julia Evangelou Strait, can be found below. Nerve axons serve as the …
Gene Therapy Blocks Peripheral Nerve Damage in Mice Read More »
The Foundation for Peripheral Neuropathy (FPN) is pleased to announce a new partnership to further research on anti-MAG IgM paraprotein-associated peripheral neuropathy. FPN will be partnering with the IMAGiNe study, a global research collaborative focusing on anti-MAG and IgM paraprotein-associated peripheral neuropathy. Thanks to a donation from the Atlantic Philanthropies Director/Employee Designated Gift Fund, FPN …
